Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates ...Middle East

Company recently acquired IND for ongoing Phase 2 clinical trial evaluating 225Ac-PSMA I&T, a small molecule radiopharmaceutical targeting PSMA positive mCRPC FPI-1434 preliminary Phase 1 data expected in Q2 2023 FPI-1966 and FPI-2059 Phase 1 trials open and recruiting patients Strong...

Hence then, the article about fusion pharmaceuticals announces fourth quarter 2022 financial results and clinical program updates was published today ( Thursday 16/03/2023 - 02:41 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates )

Also on site :

• Britney Spears Spends Time With Diane Warren and Molly Shannon After DUI
• 'You should resign': Mamata hits out at PM Modi's silence on Pakistan's threat to strike Kolkata
• This Guitarist Helped Shape One of the Most Iconic Sounds of the '90s